Sort
15,273 grants matching “antimicrobial resistance”
The pel exopolysaccharide gene cluster of Pseudomonas aeruginosa
$333,135Matthew R. Parsek · University Of Washington · R01 · FY2009 · AI
Salmonella evasion of NADPH oxidase-dependent killing
$333,085Andres Vazquez-Torres · University Of Colorado Denver · R01 · FY2006 · AI
Development, Implementation and Evaluation of Novel Strategies to Reduce Inapprop
$333,000Curtis Donskey · Case Western Reserve University · R01 · FY2008 · CI
Role of Active Efflux in Vibrio cholerae pathogenesis
$333,000James Edward Bina · University Of Tennessee Health Sci Ctr · R56 · FY2010 · AI
Reducing Antimicrobial Use Associated with Ventilator Associated Pneumonia and Ca
$333,000Sara Elizabeth Cosgrove · Johns Hopkins University · R01 · FY2008 · CI
Reducing Antimicrobial Use Associated with Ventilator Associated Pneumonia and Ca
$333,000Sara Elizabeth Cosgrove · Johns Hopkins University · R01 · FY2010 · CI
Reducing Antimicrobial Use Associated with Ventilator Associated Pneumonia and Ca
$333,000Sara Elizabeth Cosgrove · Johns Hopkins University · R01 · FY2009 · CI
Antibody-based vaginal microbicides against gonorrhea
$332,966Ann E. Jerse · Univ Of North Carolina Chapel Hill · U19 · FY2008 · AI
Oral Mucosal Immunity in Vulnerable HIV Infected Populations
$332,898Aaron Weinberg · Case Western Reserve University · P01 · FY2010 · DE
Mechanisms of Staphylococcal Co-Resistance to Daptomycin and Host Defense Peptide
$332,722Arnold S Bayer · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · R01 · FY2013 · AI
Molecular Basis of Host Parasite Interaction
$332,652David S Schneider · Stanford University · T32 · FY2014 · AI
HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infection
$332,644Simone Anne Joosten · Leiden University Medical Center · R01 · FY2022 · AI
Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment
$332,642Warren E Rose · University Of Wisconsin-Madison · R01 · FY2021 · AI
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
$332,618Richard Platt · Harvard Pilgrim Health Care, Inc. · U54 · FY2015 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
$332,618Richard Platt · Harvard Pilgrim Health Care, Inc. · U54 · FY2013 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
$332,618Richard Platt · Harvard Pilgrim Health Care, Inc. · U54 · FY2012 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
$332,618Richard Platt · Harvard Pilgrim Health Care, Inc. · U54 · FY2014 · CK
Epicenters III: Translational Research to Prevent Healthcare Associated Infection
$332,618Richard Platt · Harvard Pilgrim Health Care, Inc. · U54 · FY2011 · CK
S AUREUS PATHOGENESIS IN HIV INFECTION AND IN DRUG USE
$332,578Columbia University Health Sciences · R01 · FY2001 · DA
Infectious Disease Training in Clinical Investigation
$332,413James R Johnson · University Of Minnesota · T32 · FY2012 · AI
Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)
$332,303Christian T. Happi · Redeemer'S University · U54 · FY2025 · TW
Molecular Mechanism and Ligand Design of a PLP/GABA-dependent Bacterial Transcription Regulator GabR
$332,280Dali Liu · Loyola University Of Chicago · R15 · FY2015 · GM
Analyses of sodium bioenergetics in Vibrio cholerae
$332,240Claudia C Hase · Oregon State University · R01 · FY2008 · AI
Microbiological Characterization and Mitigation of Bioaerosols in CAFOs
$332,237Norman R Pace · University Of Colorado · R01 · FY2007 · OH
Microbiological Characterization and Mitigation of Bioaerosols in CAFOs
$332,148Norman R Pace · University Of Colorado · R01 · FY2008 · OH